Festoff, B. W., Sajja, R. K., van Dreden, P., & Cucullo, L. (2016). HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease. J Neuroinflammation.
Citação norma ChicagoFestoff, Barry W., Ravi K. Sajja, Patrick van Dreden, and Luca Cucullo. "HMGB1 and Thrombin Mediate the Blood-brain Barrier Dysfunction Acting As Biomarkers of Neuroinflammation and Progression to Neurodegeneration in Alzheimer’s Disease." J Neuroinflammation 2016.
MLA citiranjeFestoff, Barry W., Ravi K. Sajja, Patrick van Dreden, and Luca Cucullo. "HMGB1 and Thrombin Mediate the Blood-brain Barrier Dysfunction Acting As Biomarkers of Neuroinflammation and Progression to Neurodegeneration in Alzheimer’s Disease." J Neuroinflammation 2016.